Navigation Links
Dr. Timothy Rauch of Albuquerque, New Mexico Launches a Groundbreaking Cavity Prevention Program
Date:3/28/2013

Albuquerque, New Mexico (PRWEB) March 28, 2013

Dental decay is the number one chronic disease affecting American youth; surpassing both obesity and asthma. For Dr.Tim Rauch and his team those statistics are no longer daunting. They have taken the top caries research in the world and implemented a cavity prevention program developed by CariFree that is shown to decrease incidents of tooth decay by up to 74%. The system is known as CAMBRA or Caries Management by Risk Assessment. Dr. Rauch states: "I base all treatment plans on individual Risk Factors. Patients with high risk to decay are those on medications which dry the mouth, soda drinkers, and patients with acidic bacteria. With CariFree, we can combat these acid attacks, and sometimes reverse the effects of early decay. Now that is exciting!"

CAMBRA is rooted in a medical model of risk assessment. It requires the dental professional to assess each and every patient’s risk factors for the disease and then develop a personalized treatment plan to systematically lower their risk. The CariFree diagnostic tools leverage biofilm testing (to determine the levels of cavity-causing bacteria in the patient’s mouth) as well as a risk assessment questionnaire to determine the overall statistical probability a patient will develop new cavities over the next 12 months. Never before has such predictive information been available. Patients can then measurably lower their risk for decay by utilizing professional products and behavior modification.

Patients can expect the entire process to take a few minutes in their appointment. They will answer targeted questions regarding their current habits (eating and drinking, medication use, chronic health issues etc.) as well as undergo a quick, painless swab of their lower teeth (to determine if they have an excess of cavity causing bacteria). Then based on the information gathered, their dental team will counsel them on an appropriate course of action to lower their risk. If professional products are recommended the practitioner will provide the patient with a professional kit of product specifically designed to counteract their risk factors.

Science has proven that this disease cannot be stopped by the drill and fill approach. True cure requires a medical approach and a comprehensive assessment of each patient. Dr. Tim Rauch has taken a bold and caring step for his patients and his community.

For more information on the CariFree system go to http://www.carifree.com. Call now and make your appointment with Dr. Rauch and his team at 505-795-6057.

About Dr. Rauch: Dr. Rauch received his bachelor of science degree from Brigham Young University after serving in the United States Air Force. He then obtained his DDS from Marquette University School of Dentistry where he received a number of fellowships, scholarships and grants. He was also the president of his graduating Dental Class as well as the Student Body President of the Marquette School of Dentistry. He is certified as a Doctor of Dental Surgery and is a member of both the American Dental Association and the American Association of Dental Research.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10575518.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pharmaceutical Market in Mexico Expected to Reach $22.5 Billion by 2020
2. US Lab Deployed to Boost Mexicos Response to Outbreaks of Infectious Disease
3. CellHealth Institute Launches with Support from Influential Investors
4. Dr. Richard Charmoy Launches Groundbreaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
5. Elsevier Launches Web-Based Pathway Studio and Adds New Molecular Data from Its Biology Journals to Boost Early Discovery Research
6. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
7. Rockingham County Economic Development Launches New Website
8. Neogen launches rapid tests for ractopamine
9. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
10. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
11. Darrow Wealth Management Launches New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... According to a new ... Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, ... Development, Disease-Risk) - Global Forecast to 2021" published ... USD 53.34 Billion by 2021 from USD 27.95 ... 13.8% during the forecast period (2016-2021). ...
(Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
(Date:2/16/2017)... Calif. and GREENWICH, Conn. ... a private investment firm focused on venture growth ... the promotion of Josh Richardson , M.D. ... on investments in biotechnology companies.  He is a ... played important roles in Longitude,s investments in Aimmune ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor Therapeutics, ... clinical-stage biotechnology company developing first-in-class biological therapies for ... it has elected to terminate its license agreement ... receptor agonists, including Cenderitide. "Our decision ... as we prioritize our efforts to advance our ...
Breaking Biology Technology:
(Date:1/23/2017)... DENVER , Jan. 23, 2017  The latest ... biometric smartphone prices have dropped dramatically. The quarterly average ... Q1 2013 to $276 in Q4 2016.  There are ... average price of $116, up from just 28 a ... According to Maxine Most , Acuity ...
(Date:1/19/2017)... Oregon and PUNE, India , January 19, 2017 ... Research, titled, "Global Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," ... growing at a CAGR of 9.6% from 2016 to 2022. In 2015, ... owing to high-level security for both public and private sectors. ... ...
(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
Breaking Biology News(10 mins):